|
WO2012053828A2
|
|
Human interleukin-1 receptor antagonist - hybrid fc fusion protein
|
|
KR20120041139A
|
|
Human interleukin-1 receptor antagonist-hybrid fc fusion protein
|
|
KR20130030060A
|
|
System for transferring composition into skin using patch and method of controlling the same
|
|
KR20120137096A
|
|
Patch for transferring composition into skin and manufacturing the same
|
|
KR20110123881A
|
|
Improved method for producing metformin succinate
|
|
KR20100091127A
|
|
Novel salts of adefovir dipivoxil and method for the preparation of the same
|
|
KR20090013736A
|
|
Sustained-release formulation comprising metformin acid salt
|
|
KR20080092885A
|
|
Pharmaceutical composition containing water-soluble drug in semi-permeable layer for sustained delivery
|
|
KR20080009016A
|
|
Gastric retention-type pellet and the preparation method thereof
|
|
KR20070058296A
|
|
Pharmaceutical combination composition of ace-inhibitor and statins, and its manufacturing method
|
|
KR20060051510A
|
|
Pharmaceutical combination preparation for oral delivery for the treatment of diabetes mellitus
|
|
KR20070012955A
|
|
Manufacturing method for spheric granule of pancreatin
|
|
KR20060006469A
|
|
Oral antidiabetic composition comprising metformin and glimepiride and the preparation method thereof
|
|
KR100210919B1
|
|
Extract of artemisia capillaris thunburg removed toxicity and liquid type preparation containing the extracts
|
